Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Claris IPO.
April 11, 2024 12:30:00 PM
With Instacart, Arm, and Klaviyo going public, the IPO market could be reviving this year. BI profiled 11 startups that are expected to IPO, according to PitchBook's Exit Predictor. It's been a ...
Published by : Business InsiderApril 18, 2024 9:46:00 PM
Ibotta began its path as a public company on Thursday by opening at $117 per share, a big increase from its IPO price of $88, itself an increase from its proposed range of $76 to $84 per share.
Published by : TechCrunchApril 2, 2024 7:57:00 PM
The IPO market is finally starting to show some signs of life following a two-year freeze of companies going public. That suggests to LPL strategists Dr. Quincy Krosby and Jeffrey Buchbinder that ...
Published by : Business InsiderApril 18, 2024 3:44:00 AM
Ibotta and shareholders sold 6.56 million shares for $88 each, Bloomberg reported, exceeding the company�s estimated IPO price, which was put between $76 and $84. Selling the shares for $88 each ...
Published by : ForbesApril 19, 2024 2:34:00 AM
It just so happens the IPO market perked up just in time for its offering. Ibotta offers cash-back rewards and rebates for purchases at stores that include Walmart, Dollar General and Kroger.
Published by : Wall Street JournalApril 11, 2024 8:36:00 AM
The Reddit IPO will arguably go down as one of the most anticipated initial public offerings (IPOs) of 2024, and it did not disappoint. On Wednesday, March 20, the social media company priced its ...
Published by : KiplingerApril 22, 2024 3:30:00 AM
IIFL Securities and ICICI Securities are the book running lead managers for the JNK India IPO, while Link Intime India is the registrar for the issue. Nephro Care IPO: Nephro Care India Ltd has ...
Published by : Business TodayApril 3, 2024 3:29:00 AM
The financial loss comes days after reports of Bithumb facing potential internal issues that led to the delay of its planned IPO. Bitkub targets to go public on the Stock Exchange of Thailand in ...
Published by : CoinTelegraphApril 18, 2024 11:49:00 PM
The successful IPO debut of Ibotta has freshly minted more than 150 millionaires, according to CEO Bryan Leach. "By my calculations, I believe there'll be over 150 people who make at least a ...
Published by : Business InsiderApril 15, 2024 4:43:00 PM
For more on the IPO market, we're joined by Nelson Griggs. He's Nasdaq's Co-President. And alongside, our very own executive editor Brian Sozzi. Thank you both for being here this morning. Nelson ...
Published by : Yahoo FinanceApril 21, 2024 7:00:00 PM
Welcome to the IPO rollercoaster! Get ready to ride the waves of Initial Public Offerings as we dive into trends and risks. IPOs, or Initial Public Offerings, occur when a private company decides ...
Published by : Business Insider IndiaIPO Listing Detail
Listing Date: Monday, December 20, 2010
BSE Scrip Code: 533288
Listing In: 'B' Group of Securities
ISIN: INE562G01018
Issue Price: Rs. 228.00 Per Equity Share
Face Value: Rs. 10.00 Per Equity Share
Claris Lifesciences Ltd IPO allotment status is now available online.
Claris Lifesciences IPO was open on Nov 24, 2010 and closed on Dec 02, 2010. IPO of Claris was oversubscribed by 1.50 times (1.60 times in retail).
Claris Lifesciences Ltd (CLL) IPO finally subscribed 1.50 times on its closing day. Claris IPO was open on Nov 24, 2010 and closed today on Dec 02, 2010 for subscription.
Oversubscription detail
Qualified Institutional Buyers (QIBs): 1.31 Times
Non Institutional Investors: 2.03 Times
Retail Individual Investors (RIIs): 1.60 Times
Total: 1.50 Times
Alert:
Book Running Lead Manager to the issue has informed the Exchange that the CLARIS LIFESCIENCES LIMITED issue will close on 2 Dec, 2010 instead of the earlier closing day on 26 Nov, 2010.Post issue modification date has been revised to 3 Dec, 2010 instead of the earlier closing day on 27 Nov, 2010. Further price band has revised from 278/- to Rs. 293/- TO Rs. 228/- to Rs. 235/- per share
Claris Lifesciences Limited (CLL) is entering in the capital markets with an initial public offering, IPO of Rs. 300.00 Crore. The price band for the issue has been fixed at Rs 278/- at lower level and Rs 293/- at upper level.
Incorporated in 1994, Claris Lifesciences Limited (CLL) is an Ahmedabad based pharmaceutical company. Claris is the largest Indian sterile injectables pharmaceutical companies with a presence in 76 countries worldwide. Claris offers 113 products across multiple markets and therapeutic areas. All of these products are off-patent products.
The issue opens on Nov 24, 2010, and closes for subscription on Nov 26, 2010. The equity shares of the issue are proposed to be listed on the Bombay Stock Exchange (BSE).
The Claris IPO is proposed to open on November 24, 2010. The IPO application ends on December 2, 2010.
Retail investors can apply in the retail or non-institutional investor category from November 24, 2010 to December 2, 2010. The Claris IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Claris IPO will open for subscription on November 24, 2010. The public issue will close on December 2, 2010.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
